CellaVision AB (publ) (CEVI.ST)
SEK 222.0
(2.07%)
SEK 222.0
(2.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 928.71 Million SEK | 4.15% |
| 2022 | 891.74 Million SEK | 8.06% |
| 2021 | 825.21 Million SEK | 23.53% |
| 2020 | 668.02 Million SEK | 4.1% |
| 2019 | 641.7 Million SEK | 72.14% |
| 2018 | 372.78 Million SEK | 24.01% |
| 2017 | 300.59 Million SEK | 17.22% |
| 2016 | 256.44 Million SEK | 16.34% |
| 2015 | 220.42 Million SEK | 8.99% |
| 2014 | 202.24 Million SEK | 7.25% |
| 2013 | 188.57 Million SEK | 5.61% |
| 2012 | 178.55 Million SEK | -0.1% |
| 2011 | 178.72 Million SEK | 9.99% |
| 2010 | 162.5 Million SEK | 43.36% |
| 2009 | 113.35 Million SEK | 17.5% |
| 2008 | 96.47 Million SEK | 118.66% |
| 2007 | 44.12 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 957.31 Million SEK | -1.73% |
| 2024 Q3 | 983.83 Million SEK | 2.77% |
| 2024 Q1 | 974.11 Million SEK | 4.89% |
| 2023 Q4 | 928.71 Million SEK | 3.83% |
| 2023 Q1 | 897.07 Million SEK | 0.6% |
| 2023 Q2 | 898.19 Million SEK | 0.12% |
| 2023 FY | 928.71 Million SEK | 4.15% |
| 2023 Q3 | 894.44 Million SEK | -0.42% |
| 2022 Q2 | 843.33 Million SEK | -0.72% |
| 2022 Q4 | 891.74 Million SEK | 3.63% |
| 2022 FY | 891.74 Million SEK | 8.06% |
| 2022 Q1 | 849.47 Million SEK | 2.94% |
| 2022 Q3 | 860.49 Million SEK | 2.04% |
| 2021 Q4 | 825.21 Million SEK | 10.47% |
| 2021 Q1 | 707.2 Million SEK | 5.86% |
| 2021 FY | 825.21 Million SEK | 23.53% |
| 2021 Q2 | 726.22 Million SEK | 2.69% |
| 2021 Q3 | 746.98 Million SEK | 2.86% |
| 2020 Q2 | 664.86 Million SEK | -1.88% |
| 2020 Q1 | 677.59 Million SEK | 5.59% |
| 2020 FY | 668.02 Million SEK | 4.1% |
| 2020 Q4 | 668.02 Million SEK | 0.22% |
| 2020 Q3 | 666.58 Million SEK | 0.26% |
| 2019 Q1 | 418.86 Million SEK | 12.36% |
| 2019 Q2 | 417.79 Million SEK | -0.26% |
| 2019 Q4 | 641.7 Million SEK | 46.68% |
| 2019 Q3 | 437.48 Million SEK | 4.71% |
| 2019 FY | 641.7 Million SEK | 72.14% |
| 2018 Q1 | 312.22 Million SEK | 3.87% |
| 2018 Q4 | 372.78 Million SEK | 13.3% |
| 2018 FY | 372.78 Million SEK | 24.01% |
| 2018 Q3 | 329.03 Million SEK | 7.05% |
| 2018 Q2 | 307.37 Million SEK | -1.55% |
| 2017 FY | 300.59 Million SEK | 17.22% |
| 2017 Q4 | 300.59 Million SEK | 7.22% |
| 2017 Q2 | 266.15 Million SEK | -4.7% |
| 2017 Q1 | 279.28 Million SEK | 8.91% |
| 2017 Q3 | 280.36 Million SEK | 5.34% |
| 2016 Q1 | 233.58 Million SEK | 5.97% |
| 2016 Q3 | 233.35 Million SEK | 7.51% |
| 2016 Q4 | 256.44 Million SEK | 9.9% |
| 2016 Q2 | 217.04 Million SEK | -7.08% |
| 2016 FY | 256.44 Million SEK | 16.34% |
| 2015 Q2 | 182.64 Million SEK | -14.03% |
| 2015 Q4 | 220.42 Million SEK | 5.75% |
| 2015 FY | 220.42 Million SEK | 8.99% |
| 2015 Q1 | 212.46 Million SEK | 5.05% |
| 2015 Q3 | 208.45 Million SEK | 14.13% |
| 2014 Q3 | 184.57 Million SEK | 7.63% |
| 2014 Q4 | 202.24 Million SEK | 9.58% |
| 2014 Q1 | 185.99 Million SEK | -1.37% |
| 2014 FY | 202.24 Million SEK | 7.25% |
| 2014 Q2 | 171.48 Million SEK | -7.8% |
| 2013 FY | 188.57 Million SEK | 5.61% |
| 2013 Q1 | 176.04 Million SEK | -1.41% |
| 2013 Q3 | 171.27 Million SEK | 3.0% |
| 2013 Q4 | 188.57 Million SEK | 10.1% |
| 2013 Q2 | 166.29 Million SEK | -5.54% |
| 2012 Q4 | 178.55 Million SEK | -1.55% |
| 2012 Q2 | 161.92 Million SEK | -4.53% |
| 2012 Q1 | 169.6 Million SEK | -5.1% |
| 2012 FY | 178.55 Million SEK | -0.1% |
| 2012 Q3 | 181.35 Million SEK | 12.01% |
| 2011 FY | 178.72 Million SEK | 9.99% |
| 2011 Q4 | 178.72 Million SEK | 14.18% |
| 2011 Q3 | 156.53 Million SEK | -4.51% |
| 2011 Q1 | 152.91 Million SEK | -5.9% |
| 2011 Q2 | 163.92 Million SEK | 7.2% |
| 2010 Q1 | 96.58 Million SEK | -14.79% |
| 2010 Q2 | 110.32 Million SEK | 14.23% |
| 2010 FY | 162.5 Million SEK | 43.36% |
| 2010 Q3 | 122.09 Million SEK | 10.67% |
| 2010 Q4 | 162.5 Million SEK | 33.09% |
| 2009 Q3 | 90.77 Million SEK | 14.4% |
| 2009 FY | 113.35 Million SEK | 17.5% |
| 2009 Q2 | 79.34 Million SEK | 0.0% |
| 2009 Q4 | 113.35 Million SEK | 24.88% |
| 2008 FY | 96.47 Million SEK | 118.66% |
| 2008 Q4 | 96.47 Million SEK | 0.0% |
| 2007 FY | 44.12 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -1376.865% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 71.749% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 71.749% |
| Arcoma AB | 81.96 Million SEK | -1033.101% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | -36.0% |
| BICO Group AB (publ) | 10.19 Billion SEK | 90.892% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | -22.992% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -1508.856% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -4129.979% |
| C-Rad AB (publ) | 404 Million SEK | -129.879% |
| Duearity AB (publ) | 15.14 Million SEK | -6032.541% |
| Dignitana AB (publ) | 44.83 Million SEK | -1971.584% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -790.424% |
| Getinge AB (publ) | 55.09 Billion SEK | 98.314% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -804.84% |
| Iconovo AB (publ) | 128.07 Million SEK | -625.104% |
| Integrum AB (publ) | 164.85 Million SEK | -463.337% |
| Luxbright AB (publ) | 40.68 Million SEK | -2182.596% |
| Mentice AB (publ) | 322.52 Million SEK | -187.949% |
| OssDsign AB (publ) | 356.38 Million SEK | -160.589% |
| Paxman AB (publ) | 167.12 Million SEK | -455.699% |
| Promimic AB (publ) | 92.87 Million SEK | -899.959% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -2278.507% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -1343.579% |
| ScandiDos AB (publ) | 81.47 Million SEK | -1039.902% |
| Sectra AB (publ) | 3.21 Billion SEK | 71.077% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 8.416% |
| Senzime AB (publ) | 433.54 Million SEK | -114.215% |
| SpectraCure AB (publ) | 144.83 Million SEK | -541.225% |
| Stille AB | 804.89 Million SEK | -15.383% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 94.334% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 57.701% |